By definition, innovation refers to the introduction of something new or different, such as a product, method, or process. In practice, innovation has come to mean a business strategy to find a niche, adapt to changing markets, restructure an organization, maximize an organization’s strengths, or simply stay competitive.
In this “innovation” context, the editors of BioPharm International are pleased to introduce our first eBook, Biopharmaceutical Innovation Updates and Strategies. In this special publication, the editors take a look at the business side of biopharmaceuticals—strategies, practices, and opportunities to fund R&D, protect patents, establish outsourcing partnerships, and manage organizational change.
This digital publication offers added functionality versus a print magazine. You will find embedded videos, podcasts, and links that connect you to additional information and resources. We hope this eBook provides a picture of how innovation—however it is defined—is shaping the biopharmaceutical industry.
--The editors of BioPharm International
View BioPharm International's Biopharmaceutical Innovation Updates and Strategies eBook
Profile: NPS Pharmaceuticals
Leveraging Development Strengths Drives Therapies to Market
Established biopharmaceutical company NPS Pharmaceuticals uses its expertise in development, regulatory compliance, and commercialization to bring to market products with orphan drug status.
Cynthia A. Challener, PhD, Contributing Editor